<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01183000</url>
  </required_header>
  <id_info>
    <org_study_id>1789</org_study_id>
    <nct_id>NCT01183000</nct_id>
  </id_info>
  <brief_title>Closure of Peritoneum at Cesarean Section and Postoperative Adhesion</brief_title>
  <acronym>cs adhesions</acronym>
  <official_title>Effects of Closure Versus Non-closure of the Visceral and Parietal Peritoneum at Cesarean Section on Adhesions: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barzilai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barzilai Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To determine the effect of non-closure of the visceral and parietal peritoneum
      during Cesarean section on the formation of adhesions.

      Study design: A prospective randomized trial of 533 women undergoing primary Cesarean
      section; 256 were randomized to non closure and 277 to closure of the peritoneum. At a
      subsequent cesarean,he presence of adhesions and their severity was evaluated at several
      sites: between the layers of the abdominal wall, between the bladder and the abdominal wall,
      between bladder and uterus, between the uterus and the abdominal wall, and between the bowels
      and the pelvic organs. A cumulative adhesion score was calculated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2010</start_date>
  <completion_date type="Actual">December 31, 2010</completion_date>
  <primary_completion_date type="Actual">August 16, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adhesion score</measure>
    <time_frame>6 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">533</enrollment>
  <condition>Cesarean Section</condition>
  <condition>Adhesions</condition>
  <arm_group>
    <arm_group_label>peritoneal closure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non closure of the peritoneum</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Closure of the peritoneum at cs</intervention_name>
    <description>Injection of 5 mg Marcaine (anesthetic solution) to the leg</description>
    <arm_group_label>peritoneal closure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing primary CS

        Exclusion Criteria:

          -  Lack of consent by the patient or an urgent cesarean not allowing time to elicit an
             informed consent

          -  Previous pelvic or abdominal surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ofer Gemer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barzili Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78306</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilay University Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 8, 2010</study_first_submitted>
  <study_first_submitted_qc>August 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2010</study_first_posted>
  <last_update_submitted>July 10, 2019</last_update_submitted>
  <last_update_submitted_qc>July 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Barzilai Medical Center</investigator_affiliation>
    <investigator_full_name>ofer gemer</investigator_full_name>
    <investigator_title>Prof. Ofer Gemer</investigator_title>
  </responsible_party>
  <keyword>Formation of adhesions assessed at subsequent cs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

